935269-25-3 Usage
Uses
Used in Organic Synthesis:
3-OXO-2,3-DIHYDRO-1H-ISOINDOLE-4-CARBOXYLIC ACID METHYL ESTER is used as a building block in organic synthesis for the creation of various organic compounds. Its chemical properties and reactivity contribute to the formation of diverse molecular structures.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 3-OXO-2,3-DIHYDRO-1H-ISOINDOLE-4-CARBOXYLIC ACID METHYL ESTER is utilized as a starting material for the development of potential drug molecules. Its unique structure and potential biological activities are being investigated for their therapeutic potential.
Used in Research on Biological Activities:
3-OXO-2,3-DIHYDRO-1H-ISOINDOLE-4-CARBOXYLIC ACID METHYL ESTER is employed in ongoing research to explore its interactions with biological systems. This research aims to uncover its potential applications in developing novel therapeutics and chemical tools for various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 935269-25-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,5,2,6 and 9 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 935269-25:
(8*9)+(7*3)+(6*5)+(5*2)+(4*6)+(3*9)+(2*2)+(1*5)=193
193 % 10 = 3
So 935269-25-3 is a valid CAS Registry Number.
935269-25-3Relevant academic research and scientific papers
7-[1H-Indol-2-yl]-2,3-dihydro-isoindol-1-ones as dual Aurora-A/VEGF-R2 kinase inhibitors: Design, synthesis, and biological activity
Hughes, Terry V.,Emanuel, Stuart L.,O'Grady, Harold R.,Connolly, Peter J.,Rugg, Catherine,Fuentes-Pesquera, Angel R.,Karnachi, Prabha,Alexander, Richard,Middleton, Steven A.
scheme or table, p. 5130 - 5133 (2009/05/26)
A novel series of 7-[1H-indol-2-yl]-2,3-dihydro-isoindol-1-ones designed to be inhibitors of VEGF-R2 kinase was synthesized and found to potently inhibit VEGF-R2 and Aurora-A kinases. The structure-based design, synthesis, and initial SAR of the series are discussed.
SUBSTITUTED DIHYDRO-ISOINDOLONES USEFUL IN TREATING KINASE DISORDERS
-
Page/Page column 68, (2008/06/13)
The present invention is directed to novel substituted dihydro-isoindolone compounds of formula (I): and forms thereof, wherein Ring A, X3, R1, R2, R3, R4 and R6 are as herein defined, and their synthesis and use as protein kinase inhibitors and interactions thereof.
